These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9005784)

  • 1. [Fluoroquinolones--current value in antibacterial therapy, outlook for development].
    Navashin SM; Navashin PS
    Antibiot Khimioter; 1996; 41(9):4-10. PubMed ID: 9005784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fluoroquinolones--a current review].
    Christ W; Kemmler H
    Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
    Bonafede ME; Blumer JL
    Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
    [No Abstract]   [Full Text] [Related]  

  • 4. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist].
    Schurz JK
    Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fluoroquinolones: importance, development of research, new drugs, questions for discussion].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(11):38-44. PubMed ID: 10079866
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoroquinolones.
    Molavi A
    Am Fam Physician; 1988 May; 37(5):279-84. PubMed ID: 3284309
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial activity and action mechanism of ofloxacin].
    Padeĭskaia EN
    Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780
    [No Abstract]   [Full Text] [Related]  

  • 9. [The rational use of fluoroquinolones].
    Zhang Y
    Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):7-8. PubMed ID: 12795261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
    Stahlmann R; Lode H
    MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity].
    Padeĭskaia EN
    Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoroquinolones in animal health.
    Brown SA
    J Vet Pharmacol Ther; 1996 Feb; 19(1):1-14. PubMed ID: 8992019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The place of fluoroquinolones in the treatment of bacterial infections].
    Iakovlev SV
    Antibiot Khimioter; 1999; 44(12):27-30. PubMed ID: 10687031
    [No Abstract]   [Full Text] [Related]  

  • 14. Trovafloxacin: fourth generation fluoroquinolone.
    McNabb J; Nicolau D; Quintiliani R; Nightingale C
    Conn Med; 1998 Aug; 62(8):483-7. PubMed ID: 9753805
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of resistance to quinolones and current level of sensitivity of clinically important microorganisms to ofloxacin].
    Sidorenko SV; Rezvan SP; Makarova RA; Makarov AN; Kozlova NS; Ogneva NS; Korolev IuS; Gladin DP
    Antibiot Khimioter; 1996; 41(9):33-8. PubMed ID: 9005782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone.
    Park KH; Cho IH; Lee JM; Kang JA; Kim YG; Hong KH; Kim JH; Nishino T
    Drugs; 1995; 49 Suppl 2():240-2. PubMed ID: 8549317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Should the use of gyrase inhibitors be limited to hospitals?].
    Shah PM
    Immun Infekt; 1990 Jun; 18(3):69-70. PubMed ID: 2165996
    [No Abstract]   [Full Text] [Related]  

  • 18. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 19. [New antibacterial agents].
    Vaara M; Saxén H
    Duodecim; 1999; 115(20):2259-64. PubMed ID: 11973930
    [No Abstract]   [Full Text] [Related]  

  • 20. Quinolones in dermatology.
    Sable D; Murakawa GJ
    Dis Mon; 2004 Jul; 50(7):381-94. PubMed ID: 15280869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.